NASDAQ
BridgeBio Pharma, Inc. (BBIO) has a market cap of $13.46B as of Friday, May 22, 2026. The BBIO market cap is down 8.30% over the past 30 days and has grown 114.77% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.
No price data available for this timeframe.